Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62015CA0596

    Joined Cases C-596/15 P and C-597/15 P: Judgment of the Court (Third Chamber) of 23 November 2017 — Bionorica SE (C-596/15 P), Diapharm GmbH & Co. KG (C-597/15 P) v European Commission (Appeal — Public health — Consumer protection — Regulation (EC) No 1924/2006 — Health claims on foods — Article 13(3) — List of permitted health claims on foods — Botanical substances — Claims on hold — Action for failure to act — Article 265 TFEU — Defined position of the European Commission — Interest in bringing proceedings — Locus standi)

    OJ C 22, 22.1.2018, p. 3–3 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    22.1.2018   

    EN

    Official Journal of the European Union

    C 22/3


    Judgment of the Court (Third Chamber) of 23 November 2017 — Bionorica SE (C-596/15 P), Diapharm GmbH & Co. KG (C-597/15 P) v European Commission

    (Joined Cases C-596/15 P and C-597/15 P) (1)

    ((Appeal - Public health - Consumer protection - Regulation (EC) No 1924/2006 - Health claims on foods - Article 13(3) - List of permitted health claims on foods - Botanical substances - Claims on hold - Action for failure to act - Article 265 TFEU - Defined position of the European Commission - Interest in bringing proceedings - Locus standi))

    (2018/C 022/03)

    Language of the case: German

    Parties

    Appellants: Bionorica SE (C-596/15 P), Diapharm GmbH & Co. KG (C-597/15 P) (represented by: M. Weidner, T. Guttau and N. Hußmann, Rechtsanwälte)

    Other party to the proceedings: European Commission (represented by: S. Grünheid and M. Wilderspin, acting as Agents)

    Operative part of the judgment

    The Court:

    1.

    Sets aside the order of the General Court of the European Union of 16 September 2015, Bionorica v Commission (T-619/14, not published, EU:T:2015:723);

    2.

    Dismisses the action for failure to act lodged by Bionorica SE in Case T-619/14 as inadmissible;

    3.

    Dismisses the appeal in Case C-597/15 P;

    4.

    Orders Bionorica SE and the Commission each to bear their own costs incurred both at first instance in Case T-619/14 and on appeal in Case C-596/15 P;

    5.

    Orders Diapharm GmbH & Co. KG to pay the costs incurred on appeal in Case C-597/15 P.


    (1)  OJ C 16, 18.1.2016.


    Top